Last Updated: November 16, 2026

ISENTRESS HD Drug Patent Profile

« Back to Dashboard


Which patents cover Isentress Hd, and when can generic versions of Isentress Hd launch?

Isentress Hd is a drug marketed by Msd Sub Merck and is included in one NDA. There are four patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in ISENTRESS HD is raltegravir potassium. Six suppliers are listed for this compound. Additional details are available on the raltegravir potassium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Isentress Hd

A generic version of ISENTRESS HD was approved as raltegravir potassium by HETERO LABS LTD III on December 19th, 2024.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for ISENTRESS HD?
  • What are the global sales for ISENTRESS HD?
  • What is Average Wholesale Price for ISENTRESS HD?
Summary for ISENTRESS HD
Paragraph IV (Patent) Challenges for ISENTRESS HD
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ISENTRESS HD Tablets raltegravir potassium 600 mg 022145 1 2022-10-21
ISENTRESS HD Tablets raltegravir potassium 400 mg 022145 1 2011-10-12

US Patents and Regulatory Information for ISENTRESS HD

ISENTRESS HD is protected by four US patents.

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Msd Sub Merck ISENTRESS HD raltegravir potassium TABLET;ORAL 022145-002 May 26, 2017 AB RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y Y ⤷  Start Trial
Msd Sub Merck ISENTRESS HD raltegravir potassium TABLET;ORAL 022145-002 May 26, 2017 AB RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Msd Sub Merck ISENTRESS HD raltegravir potassium TABLET;ORAL 022145-002 May 26, 2017 AB RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for ISENTRESS HD

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1441735 DO 67; 3-2008 Slovakia ⤷  Start Trial PRODUCT NAME: RALTEGRAVIR; REGISTRATION NO/DATE: Registration in Community EU/1/07/436/001-002 20071220; FORMER OWNER: ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA. IT
1441735 SPC010/2008 Ireland ⤷  Start Trial SPC010/2008: 20091119, EXPIRES: 20221219
1441735 67 3-2008 Slovakia ⤷  Start Trial PRODUCT NAME: RALTEGRAVIR; REGISTRATION NO/DATE: EU/1/07/436/001 - EU/1/07/436/002 20080102
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.